Carmell (CTCX) Competitors $2.84 +0.01 (+0.35%) As of 08/4/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CTCX vs. RXST, OM, SNWV, STIM, CLPT, CATX, NPCE, NNOX, NYXH, and DRTSShould you be buying Carmell stock or one of its competitors? The main competitors of Carmell include RxSight (RXST), Outset Medical (OM), Sanuwave Health (SNWV), Neuronetics (STIM), ClearPoint Neuro (CLPT), Perspective Therapeutics (CATX), NeuroPace (NPCE), Nano-X Imaging (NNOX), Nyxoah (NYXH), and Alpha Tau Medical (DRTS). These companies are all part of the "medical equipment" industry. Carmell vs. Its Competitors RxSight Outset Medical Sanuwave Health Neuronetics ClearPoint Neuro Perspective Therapeutics NeuroPace Nano-X Imaging Nyxoah Alpha Tau Medical Carmell (NASDAQ:CTCX) and RxSight (NASDAQ:RXST) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, valuation, dividends, profitability and analyst recommendations. Is CTCX or RXST more profitable? Carmell has a net margin of 0.00% compared to RxSight's net margin of -17.90%. RxSight's return on equity of -9.54% beat Carmell's return on equity.Company Net Margins Return on Equity Return on Assets CarmellN/A -217.50% -50.22% RxSight -17.90%-9.54%-8.51% Do institutionals & insiders believe in CTCX or RXST? 24.2% of Carmell shares are owned by institutional investors. Comparatively, 78.8% of RxSight shares are owned by institutional investors. 29.0% of Carmell shares are owned by insiders. Comparatively, 9.6% of RxSight shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has better valuation and earnings, CTCX or RXST? Carmell has higher earnings, but lower revenue than RxSight. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCarmell$32.84K1,807.92-$15.44MN/AN/ARxSight$139.93M2.19-$27.45M-$0.67-11.27 Does the media favor CTCX or RXST? In the previous week, RxSight had 35 more articles in the media than Carmell. MarketBeat recorded 35 mentions for RxSight and 0 mentions for Carmell. RxSight's average media sentiment score of 0.10 beat Carmell's score of 0.00 indicating that RxSight is being referred to more favorably in the news media. Company Overall Sentiment Carmell Neutral RxSight Neutral Do analysts recommend CTCX or RXST? RxSight has a consensus price target of $12.22, indicating a potential upside of 61.88%. Given RxSight's stronger consensus rating and higher probable upside, analysts plainly believe RxSight is more favorable than Carmell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Carmell 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00RxSight 2 Sell rating(s) 8 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.91 Which has more volatility and risk, CTCX or RXST? Carmell has a beta of 0.51, meaning that its stock price is 49% less volatile than the S&P 500. Comparatively, RxSight has a beta of 1.16, meaning that its stock price is 16% more volatile than the S&P 500. SummaryRxSight beats Carmell on 10 of the 14 factors compared between the two stocks. Get Carmell News Delivered to You Automatically Sign up to receive the latest news and ratings for CTCX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CTCX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTCX vs. The Competition Export to ExcelMetricCarmellSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$59.37M$68.95M$5.57B$9.47BDividend YieldN/AN/A4.31%4.17%P/E RatioN/A7.2829.4423.99Price / Sales1,807.92103.80448.01188.34Price / CashN/A18.4135.8458.51Price / Book2.656.768.075.58Net Income-$15.44M-$26.22M$3.26B$265.35M7 Day Performance-2.74%0.93%0.48%-0.07%1 Month Performance16.39%5.81%4.86%1.76%1 Year Performance162.96%46.94%30.22%25.39% Carmell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTCXCarmellN/A$2.84+0.4%N/A+158.2%$59.37M$32.84K0.0014RXSTRxSight3.2975 of 5 stars$7.83-0.5%$17.50+123.5%-84.2%$318.19M$148.31M-11.69220Trending NewsOMOutset Medical1.8748 of 5 stars$17.54-2.8%$29.50+68.2%-75.1%$310.84M$115.27M-0.60520News CoverageSNWVSanuwave Health2.2463 of 5 stars$34.76-2.8%$49.00+41.0%N/A$297.89M$32.63M-7.6340STIMNeuronetics1.1712 of 5 stars$4.47-1.1%$5.50+23.0%+135.6%$295.51M$74.89M-3.41180Trending NewsEarnings ReportAnalyst ForecastCLPTClearPoint Neuro2.8413 of 5 stars$10.55-3.8%$25.00+137.0%+61.8%$295.28M$32.24M-13.88110News CoveragePositive NewsUpcoming EarningsCATXPerspective Therapeutics2.518 of 5 stars$3.92-4.9%$12.56+220.3%-69.1%$290.97MN/A0.0070News CoverageUpcoming EarningsNPCENeuroPace3.1159 of 5 stars$8.78+0.5%$17.00+93.6%+23.5%$287.98M$84.31M-10.45170News CoverageUpcoming EarningsNNOXNano-X Imaging1.9576 of 5 stars$4.89-4.9%$9.50+94.3%-35.6%$282.54M$11.55M-5.43190News CoverageUpcoming EarningsNYXHNyxoah2.5987 of 5 stars$7.48+4.3%$14.50+93.9%-5.4%$254.77M$4.36M-3.51110Gap UpDRTSAlpha Tau Medical2.2382 of 5 stars$2.90-3.3%$8.00+175.9%+55.7%$245.98MN/A-6.3080News CoveragePositive NewsUpcoming Earnings Related Companies and Tools Related Companies RXST Alternatives OM Alternatives SNWV Alternatives STIM Alternatives CLPT Alternatives CATX Alternatives NPCE Alternatives NNOX Alternatives NYXH Alternatives DRTS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CTCX) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredSell these "safe" blue chips immediatelyInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carmell Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carmell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CTCX Stock Alerts